| Product NDC: | 16590-891 |
| Proprietary Name: | LANSOPRAZOLE |
| Non Proprietary Name: | LANSOPRAZOLE |
| Active Ingredient(s): | 30 mg/1 & nbsp; LANSOPRAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-891 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020406 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20091111 |
| Package NDC: | 16590-891-60 |
| Package Description: | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-891-60) |
| NDC Code | 16590-891-60 |
| Proprietary Name | LANSOPRAZOLE |
| Package Description | 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (16590-891-60) |
| Product NDC | 16590-891 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LANSOPRAZOLE |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20091111 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | LANSOPRAZOLE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |